(Q40073137)

17 September 2017

title

Self-reactivity in the dimeric intravenous immunoglobulin fraction (English)

1 reference

17 September 2017

Alexander Schaub

1

1 reference

17 September 2017

Sandra Wymann

2

1 reference

17 September 2017

Manfred Heller

3

1 reference

17 September 2017

Marco Ghielmetti

4

1 reference

17 September 2017

Zsuzsanne Beleznay

5

1 reference

17 September 2017

Beda M Stadler

6

1 reference

17 September 2017

Reinhard Bolli

7

1 reference

17 September 2017

Sylvia Miescher

8

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Annals of the New York Academy of Sciences

17 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 September 2017

volume

1110

1 reference

17 September 2017

page(s)

681-693

1 reference

The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

IVIG--mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Immunoglobulin G dimer: an idiotype-anti-idiotype complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Dimer formation in immunoglobulin preparations and speculations on the mechanism of action of intravenous immune globulin in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Autoreactive antibody repertoire is perturbed in atherosclerotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Analysis of human self-reactive antibody repertoires by quantitative immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

The role of pathogenic B-cell clones in antibody mediated autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

The natural autoantibodies system: between hypotheses and facts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

High dose intravenous immunoglobulin treatment: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

The targets of nephritogenic antibodies in systemic autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Alpha-enolase: a target of antibodies in infectious and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Galectins as inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

Self-reactive antibodies (natural autoantibodies) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.071

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1423.071

1 reference

17 September 2017

1 reference